Amphastar Pharmaceuticals (AMPH) Shares Repurchased (2013 - 2026)

Amphastar Pharmaceuticals' Shares Repurchased history runs 14 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• In Q1 2026, Shares Repurchased rose 168.11% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $94.1 million (up 6.96% YoY), while the FY2025 annual figure was $75.6 million, down 11.55% from the prior year.
• Shares Repurchased was $29.5 million for Q1 2026 at Amphastar Pharmaceuticals, up from $20.5 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $50.0 million in Q3 2023 to a low of $128000.0 in Q2 2023.
• Historically, Shares Repurchased has averaged $20.0 million across 5 years, with a median of $16.3 million in 2022.
• Biggest YoY gain for Shares Repurchased was 552.16% in 2023; the steepest drop was 97.91% in 2023.
• A 5-year view of Shares Repurchased shows it stood at $18.1 million in 2022, then jumped by 176.72% to $50.0 million in 2023, then slipped by 16.0% to $42.0 million in 2024, then sank by 51.15% to $20.5 million in 2025, then surged by 43.75% to $29.5 million in 2026.
• The last three Shares Repurchased figures came in at $29.5 million (Q1 2026), $20.5 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.